MedPath
HSA Approval

GAVISCON DOUBLE ACTION TABLETS

SIN14194P

GAVISCON DOUBLE ACTION TABLETS

GAVISCON DOUBLE ACTION TABLETS

July 17, 2012

RECKITT BENCKISER (SINGAPORE) PTE LTD

RECKITT BENCKISER (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRECKITT BENCKISER (SINGAPORE) PTE LTD
Licence HolderRECKITT BENCKISER (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET, CHEWABLE

ORAL

Medical Information

A02BX13

alginic acid

Manufacturer Information

RECKITT BENCKISER (SINGAPORE) PTE LTD

RECKITT BENCKISER HEALTHCARE (UK) LIMITED

Active Ingredients

CALCIUM CARBONATE

187.5MG

Calcium carbonate

SODIUM BICARBONATE

106.5MG

Sodium bicarbonate

SODIUM ALGINATE

250MG

Alginic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.